The Food and Drug Administration ordered stronger warnings Thursday on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the risk of possibly fatal fungal infections.
The Food and Drug Administration ordered stronger warnings Thursday on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the risk of possibly fatal fungal infections.
Schering-Plough may have lost billions of dollars in the fourth quarter from an acquisition, but its stock jumped Tuesday as the drugmaker's earnings without charges beat expectations.
Psoriasis is an inflammatory skin condition that affects up to 5 million Americans. CNN learned more about psoriasis from Dr. Mathew Avram, director of the Massachusetts General Hospital Dermatology Laser and Cosmetics Center.
Senior Democrats and Republicans in Congress are hard at work on bills that would provide millions of Americans with cheaper copies of biotech drugs that can cost hundreds of thousands of dollars a year, a news report said Saturday.
The Food and Drug Administration ordered stronger warnings Thursday on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the risk of possibly fatal fungal infections.
The Food and Drug Administration ordered stronger warnings Thursday on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the risk of possibly fatal fungal infections.
Schering-Plough may have lost billions of dollars in the fourth quarter from an acquisition, but its stock jumped Tuesday as the drugmaker's earnings without charges beat expectations.
Psoriasis is an inflammatory skin condition that affects up to 5 million Americans. CNN learned more about psoriasis from Dr. Mathew Avram, director of the Massachusetts General Hospital Dermatology Laser and Cosmetics Center.
Senior Democrats and Republicans in Congress are hard at work on bills that would provide millions of Americans with cheaper copies of biotech drugs that can cost hundreds of thousands of dollars a year, a news report said Saturday.
Abbott Labs' fast-growing flagship drug Humira is grabbing market share and making money ... and now the company is trying to win the blessings of the FDA to make more.
Amgen Inc., the world's biggest biotech developer, beat earnings expectations for the first quarter Tuesday, but analysts were still skeptical about the company's performance.
Drug safety made headlines in the major medical journals this week when noted Cleveland Clinic cardiologists came up with a disturbing analysis about a new diabetes drug that is just a hair away from approval by the Food and Drug Administration.
The black box label is the most potent warning in the Food and Drug Administration's arsenal, but it is not necessarily a death knell for drug sales, analysts say.
Johnson & Johnson says its rheumatoid arthritis drug Remicade may put patients at higher risk for lymphoma, and the company is sending out warning letters to physicians.
A common thread connects this year's standouts: They all responded to crisis by radically changing the way they make things. Autoliv reprocessed its factory to fend off stiff competition in airbags...
The Empire State ballroom at the Grand Hyatt Hotel in midtown Manhattan typically serves as the setting for the kind of stuffy, state-of-a-business luncheons that are more snooze inducing than buzz...
The economy seems to be chugging back onto the right track, and Wall Street wisdom (no jokes, please) has stocks rising this year after two consecutive annual declines. But before you jump for joy,...
For years Amgen has seemed biotechnology's best answer to the likes of Merck--a sector leader with so much heft and momentum that you'd recommend its stock to your mom. But now making that analogy ...
The first wave in biotechnology investing arrived back in the late 1980s, when revolutionary new medicines created by pioneers like Amgen alerted investors to the fledgling sector's potential. The ...
On Dec. 17, Amgen, the flagship company of the biotechnology world, closed the biggest merger in the sector's history. It agreed to pay $16 billion to buy rival Immunex, primarily for the right to ...
Patients who want the rheumatoid arthritis-fighting drug Enbrel have to show a special card to their pharmacist, who then verifies that the patient is enrolled in the Enbrel program before dispensi...
Like any good family practitioner, Dr. Reginald Parker believes in protecting against loss. So he begins his financial exams with some basic questions: What stocks do the mutual funds own? What ind...
In a dimly lit operating room at the Thompson Cancer Survival Center in Knoxville, Tennessee, a surgeon uses an endoscope to guide an optical fiber down the throat of a patient afflicted with cance...
The page you requested cannot be found. The page you are looking for might have been removed, had its name changed, or is temporarily unavailable.
Please try the following:
• If you typed the page address in the Address bar, make sure that it is spelled correctly.
• Open the edition.cnn.com home page and look for links to the information you want.
• Use the navigation bar above to find the link you are looking for.
• Click the Back button to try another link.
• Enter a term in the search form below to look for information on CNN sites or the Internet.
Video
